UBS Group AG - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$72,005
+181.8%
12,163
+349.8%
0.00%
Q1 2023$25,553
-25.8%
2,704
-16.4%
0.00%
Q4 2022$34,453
+165.0%
3,235
+76.2%
0.00%
Q3 2022$13,0001,836
+5000.0%
0.00%
Q2 2022$036
-28.0%
0.00%
Q4 2021$0
-100.0%
50
-66.7%
0.00%
Q3 2021$1,000
-95.5%
150
-94.7%
0.00%
Q2 2021$22,000
+2100.0%
2,843
+1795.3%
0.00%
Q1 2021$1,0001500.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Corton Capital Inc. 13,966$103,0000.13%
Delphia (USA) Inc. 14,226$105,0000.12%
Sentinus, LLC 22,500$166,0000.10%
Intrepid Financial Planning Group LLC 20,000$148,0000.08%
PERRITT CAPITAL MANAGEMENT INC 12,000$89,0000.06%
J. Goldman & Co LP 148,738$1,098,0000.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 88,966$657,0000.02%
EMFO, LLC 1,666$12,0000.01%
Virtu Financial LLC 12,590$93,0000.01%
Jump Financial, LLC 23,400$173,0000.01%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders